| Christine Gross, MD, PHD | |
|
955 Ribaut Rd, Beaufort, SC 29902-5454 | |
| (843) 522-5200 | |
| (318) 232-5478 |
| Full Name | Christine Gross |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Location | 955 Ribaut Rd, Beaufort, South Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710447321 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 89746 (South Carolina) | Primary |
| Entity Name | Hospital Physician Services - Southeast Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760410385 PECOS PAC ID: 5597774554 Enrollment ID: O20100107000067 |
News Archive
GlaxoSmithKline, Philadelphia, PA, USA (GSK) and Merck & Co., Inc., Whitehouse Station, NJ, USA (Merck), announced today that they have entered into an agreement for over-the-counter (OTC) marketing rights for MEVACOR (lovastatin).
A new study has found that having a portable heart defibrillator does not raise the chances of survival in people who have heart attacks in their homes.
By developing the first statistical model to finely characterize how ketamine anesthesia affects the brain, a team of researchers at MIT's Picower Institute for Learning and Memory and Massachusetts General Hospital have laid new groundwork for three advances: understanding how ketamine induces anesthesia; monitoring the unconsciousness of patients in surgery; and applying a new method of analyzing brain activity.
There is no evidence that antioxidant supplements interfere with the therapeutic effects of chemotherapy agents, according to a recent systematic review of the use of antioxidants during chemotherapy, available in the May, 2007 issue of the journal Cancer Treatment Reviews.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christine Gross, MD, PHD 955 Ribaut Rd, Beaufort, SC 29902-5454 Ph: () - | Christine Gross, MD, PHD 955 Ribaut Rd, Beaufort, SC 29902-5454 Ph: (843) 522-5200 |
News Archive
GlaxoSmithKline, Philadelphia, PA, USA (GSK) and Merck & Co., Inc., Whitehouse Station, NJ, USA (Merck), announced today that they have entered into an agreement for over-the-counter (OTC) marketing rights for MEVACOR (lovastatin).
A new study has found that having a portable heart defibrillator does not raise the chances of survival in people who have heart attacks in their homes.
By developing the first statistical model to finely characterize how ketamine anesthesia affects the brain, a team of researchers at MIT's Picower Institute for Learning and Memory and Massachusetts General Hospital have laid new groundwork for three advances: understanding how ketamine induces anesthesia; monitoring the unconsciousness of patients in surgery; and applying a new method of analyzing brain activity.
There is no evidence that antioxidant supplements interfere with the therapeutic effects of chemotherapy agents, according to a recent systematic review of the use of antioxidants during chemotherapy, available in the May, 2007 issue of the journal Cancer Treatment Reviews.
› Verified 9 days ago